Skip to main content

Iopamidol: new, nonionic contrast agent for excretory urography.

Publication ,  Journal Article
Thompson, WM; Foster, WL; Halvorsen, RA; Dunnick, NR; Rommel, AJ; Bates, M
Published in: AJR Am J Roentgenol
February 1984

Iopamidol, a new, nonionic contrast agent, was evaluated in 18 patients undergoing excretory urography. None of the 18 patients experienced any side effects or adverse reactions. No abnormalities were noted in serum chemistries, complete blood cell counts, urinalyses, or electrocardiograms. The half-life of iopamidol in 17 patients with normal renal function was 2.5 hr. The urograms were judged to be of good or excellent quality in 15 of 16 patients using doses of 200 and 250 mg l/kg of iopamidol. Two patients who were studied using a dose of only 120 mg l/kg had urograms rated poor. Fifteen iopamidol urograms (mean iodine dose, 17.4 g) were compared in a blind fashion with 15 meglumine diatrizoate studies (iodine dose, 29 g). No qualitative difference could be detected between the two groups of urograms. Iopamidol may provide equal-quality diagnostic studies with a lower iodine dose and perhaps greater safety than the currently used ionic agents.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AJR Am J Roentgenol

DOI

ISSN

0361-803X

Publication Date

February 1984

Volume

142

Issue

2

Start / End Page

329 / 332

Location

United States

Related Subject Headings

  • Urography
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Iothalamic Acid
  • Iopamidol
  • Humans
  • Half-Life
  • Diatrizoate Meglumine
  • Contrast Media
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, W. M., Foster, W. L., Halvorsen, R. A., Dunnick, N. R., Rommel, A. J., & Bates, M. (1984). Iopamidol: new, nonionic contrast agent for excretory urography. AJR Am J Roentgenol, 142(2), 329–332. https://doi.org/10.2214/ajr.142.2.329
Thompson, W. M., W. L. Foster, R. A. Halvorsen, N. R. Dunnick, A. J. Rommel, and M. Bates. “Iopamidol: new, nonionic contrast agent for excretory urography.AJR Am J Roentgenol 142, no. 2 (February 1984): 329–32. https://doi.org/10.2214/ajr.142.2.329.
Thompson WM, Foster WL, Halvorsen RA, Dunnick NR, Rommel AJ, Bates M. Iopamidol: new, nonionic contrast agent for excretory urography. AJR Am J Roentgenol. 1984 Feb;142(2):329–32.
Thompson, W. M., et al. “Iopamidol: new, nonionic contrast agent for excretory urography.AJR Am J Roentgenol, vol. 142, no. 2, Feb. 1984, pp. 329–32. Pubmed, doi:10.2214/ajr.142.2.329.
Thompson WM, Foster WL, Halvorsen RA, Dunnick NR, Rommel AJ, Bates M. Iopamidol: new, nonionic contrast agent for excretory urography. AJR Am J Roentgenol. 1984 Feb;142(2):329–332.

Published In

AJR Am J Roentgenol

DOI

ISSN

0361-803X

Publication Date

February 1984

Volume

142

Issue

2

Start / End Page

329 / 332

Location

United States

Related Subject Headings

  • Urography
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Iothalamic Acid
  • Iopamidol
  • Humans
  • Half-Life
  • Diatrizoate Meglumine
  • Contrast Media